Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Fulgent Genetics Inc 4399 SANTA ANITA AVENUE EL MONTE CA 91731 USA

www.fulgentgenetics.com Employees: 1,315 P: 626-350-0537 F: 626-454-1667

Sector:

Medical

Description:

Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.

Key Statistics

Overview:

Market Capitalization, $K 488,141
Enterprise Value, $K 437,951
Shares Outstanding, K 31,231
Float, K 20,890
% Float 66.89%
Short Interest, K 2,136
Short Float 6.84%
Days to Cover 2.19
Short Volume Ratio 0.71
% of Insider Shareholders 33.11%
% of Institutional Shareholders 48.06%

Financials:

Annual Sales, $ 322,670 K
Annual Net Income, $ -60,510 K
Last Quarter Sales, $ 83,340 K
Last Quarter Net Income, $ -23,420 K
EBIT, $ -83,070 K
EBITDA, $ -64,050 K

Growth:

1-Year Return -6.74%
3-Year Return -49.55%
5-Year Return -81.70%
5-Year Revenue Growth -23.49%
5-Year Earnings Growth -108.36%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.16 on 02/27/26
Next Earnings Date 05/01/26
Earnings Per Share ttm -0.82
EPS Growth vs. Prev Qtr 31.25%
EPS Growth vs. Prev Year 52.17%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

FLGT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2.22%
Return-on-Assets % -2.05%
Profit Margin % -18.75%
Debt/Equity 0.00
Price/Sales 1.51
Price/Cash Flow N/A
Price/Book 0.44
Book Value/Share 35.80
Interest Coverage -874.38
60-Month Beta 0.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.